Role of proteolytic enzymes in human prostate bone metastasis formation: In vivo and in vitro studies

British Journal of Cancer

Volumn 86, Issue 7, 2002, Pages 1136-1142

  Hart, C A ^a   Scott, L J ^a   Bagley, S ^a   Bryden, A A G ^a   Clarke, N W ^a   Lang, S H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bone marrow stroma; Matrix metalloproteinase; Metastasis; Prostate cancer; Prostate epithelia; Urokinase plasminogen activator

Indexed keywords

INTERSTITIAL COLLAGENASE; MATRILYSIN; UROKINASE;

ARTICLE; BONE MARROW; BONE MARROW METASTASIS; BONE METASTASIS; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

EID: 0037041640     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600207     Document Type: Article

References (30)

1. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo
2. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: Differentiation pattern of non-tumourigenic cell lines
3. Parathyroid hormone-related peptide: Expression in prostate cancer bone metastases
4. The challenge we face
5. Clonal and long-term cultures using human bone marrow
6. Changing views of the role of matrix metalloproteinases in metastasis
7. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells
8. Conservative management of prostate cancer
9. Overview of matrix metalloproteinase expression in cultured human cells
10. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
11. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
12. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines
13. Spread of prostatic cancer to bone
14. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
15. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
16. Plasminogen activator activity in bone marrow metastases of prostatic carcinomas as compared to primary tumors
17. Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma
18. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates
19. Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma
20. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin
21. Optimisation of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells
22. Molecular prediction of progression of prostate cancer in conservatively managed patients
23. Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma
24. Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer
25. Expression of metalloproteinase genes in human prostate cancer
26. Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts
27. Proteases in invasion: Matrix metalloproteinases
28. Differential expression of collagenase by human fibroblasts and bone marrow stromal cells
29. Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
30. Tumour cell growth and metastatic spread: An introductory overview